Tobi, an inhaled version of tobramycin

February 1998

    The FDA just approved Tobi, an INHALED version of tobramycin...to control lung infections in patients with cystic fibrosis.

    These patients often use INJECTABLE tobramycin solution and put it in a nebulizer.

    But Tobi is formulated specifically for inhalation...it doesn't take as long to nebulize and it may be better tolerated.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote